Deans' stroke musings: The Walnuts and Healthy Aging study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, January 9, 2017

The Walnuts and Healthy Aging study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging

You'll have to ask your doctor which nuts are best and how much to eat.

New research shows almonds reduce the risk of heart disease

Go Nuts to Age Well: 6 Benefits of Nuts for Older Adults

Nuts and peanuts, but not peanut butter, may protect against death from cancer, heart disease, respiratory disease, and other major causes

The latest here:

The Walnuts and Healthy Aging study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging

Sujatha Rajaram²,

Cinta Valls-Pedret¹, Montserrat Cofan¹,

Joan Sabaté², Mercè Serra-Mir¹, Ana M Pérez-Heras¹, Adam Arechiga², Ricardo P Casaroli-Marano¹, Socorro Alforja¹,

Aleix Sala-Vila¹, Mónica Doménech¹, Irene Roth¹, Tania M Freitas-Simoes¹, Carlos Calvo¹, Anna López-Illamola¹, Ella Haddad², Natalie Kazzi², Lynnley Huey², Joseph Fan²,

Edward Bitok² and

Emilio Ros^1*

¹Hospital Clínic de Barcelona, Spain
²Loma Linda University, USA

Introduction: An unwanted consequence of population aging is the growing number of elderly at risk of neurodegenerative disorders, including dementia and macular degeneration. As nutritional and behavioral changes can delay disease progression, we designed the Walnuts and Healthy Aging (WAHA) study, a two-center, randomized, 2-year clinical trial conducted in free-living, cognitively healthy elderly men and women. Our interest in exploring the role of walnuts in maintaining cognitive and retinal health is based on extensive evidence supporting their cardio-protective and vascular health effects, which are linked to bioactive components such as n-3 fatty acids and polyphenols.
Methods: The primary aim of WAHA is to examine the effects of ingesting walnuts daily for 2 years on cognitive function and retinal health, assessed with a battery of neuropsychological tests and optical coherence tomography, respectively. All participants followed their habitual diet, adding walnuts at 15% of energy (~30-60 g/d) (walnut group) or abstaining from walnuts (control group). Secondary outcomes include changes in adiposity, blood pressure, and serum and urinary biomarkers in all participants and brain magnetic resonance imaging in a subset.
Results: From May 2012 to May 2014, 708 participants (mean age 69 years, 68% women) were randomized. The study ended in May 2016 with a 90% retention rate. Discussion: The results of WAHA might provide high-level evidence of the benefit of regular walnut consumption in delaying the onset of age-related cognitive impairment and retinal pathology. The findings should translate into public health policy and sound recommendations to the general population. (ClinicalTrials.gov identifier NCT01634841).

Keywords: cognitive decline, Alzheimer’s disease (AD), age-related macular degeneration (AMD), dietary intervention, walnuts, randomized trial, Aging
Citation: Rajaram S, Valls-Pedret C, Cofan M, Sabaté J, Serra-Mir M, Pérez-Heras A, Arechiga A, Casaroli-Marano R, Alforja S, Sala-Vila A, Doménech M, Roth I, Freitas-Simoes T, Calvo C, López-Illamola A, Haddad E, Kazzi N, Huey L, Fan J, Bitok E and Ros E (2016). The Walnuts and Healthy Aging study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging. Front. Aging Neurosci. 8:333. doi: 10.3389/fnagi.2016.00333